What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Myocardial infarction
- Surgery
His scientific interests lie mostly in Internal medicine, Myocardial infarction, Cardiology, Unstable angina and Percutaneous coronary intervention.
His work on Internal medicine is being expanded to include thematically relevant topics such as Surgery.
His Myocardial infarction research integrates issues from Retrospective cohort study, Mortality rate, Heart failure and Intensive care medicine.
His work deals with themes such as Angiography, Severity of illness, Kidney disease and Risk factor, which intersect with Cardiology.
The Unstable angina study combines topics in areas such as Antithrombotic, Eptifibatide, Clopidogrel, Aspirin and Angina.
His Percutaneous coronary intervention research incorporates elements of Reperfusion therapy, Conventional PCI and Angioplasty.
His most cited work include:
- Baseline Risk of Major Bleeding in Non–ST-Segment–Elevation Myocardial Infarction The CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) Bleeding Score (694 citations)
- Prasugrel versus clopidogrel for acute coronary syndromes without revascularization (649 citations)
- Association between hospital process performance and outcomes among patients with acute coronary syndromes. (605 citations)
What are the main themes of his work throughout his whole career to date?
Matthew T. Roe mostly deals with Internal medicine, Cardiology, Myocardial infarction, Percutaneous coronary intervention and Acute coronary syndrome.
He frequently studies issues relating to Surgery and Internal medicine.
His Cardiology research incorporates themes from Odds ratio and Platelet aggregation inhibitor.
His studies in Myocardial infarction integrate themes in fields like Stroke, Intensive care medicine, Heart failure and Emergency medicine.
His Percutaneous coronary intervention research incorporates themes from Reperfusion therapy, Artery, Conventional PCI, Angioplasty and Cardiogenic shock.
His studies in Acute coronary syndrome integrate themes in fields like Clinical trial, Randomized controlled trial, Antithrombotic and Hazard ratio.
He most often published in these fields:
- Internal medicine (74.97%)
- Cardiology (58.46%)
- Myocardial infarction (52.77%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (74.97%)
- Cardiology (58.46%)
- Myocardial infarction (52.77%)
In recent papers he was focusing on the following fields of study:
Matthew T. Roe mainly investigates Internal medicine, Cardiology, Myocardial infarction, Acute coronary syndrome and Alirocumab.
His work in Hazard ratio, Randomized controlled trial, Stroke, Clopidogrel and Clinical trial are all subfields of Internal medicine research.
His work in the fields of Cardiology, such as Conventional PCI, Coronary artery disease and Atrial fibrillation, overlaps with other areas such as In patient.
His work carried out in the field of Myocardial infarction brings together such families of science as Heart failure and Emergency medicine.
The concepts of his Acute coronary syndrome study are interwoven with issues in Adverse effect, Lipoprotein and Cohort.
His research integrates issues of Emergency medical services and Cardiac catheterization in his study of Percutaneous coronary intervention.
Between 2017 and 2021, his most popular works were:
- Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial (555 citations)
- Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events: The ODYSSEY OUTCOMES Trial (84 citations)
- Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome. (82 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Myocardial infarction
- Surgery
Matthew T. Roe mainly focuses on Internal medicine, Cardiology, Alirocumab, Acute coronary syndrome and Myocardial infarction.
As a member of one scientific family, he mostly works in the field of Internal medicine, focusing on Placebo and, on occasion, Tolerability and Confidence interval.
His work on Obstructive hypertrophic cardiomyopathy, Muscle hypertrophy, LV outflow and Cardiomyopathy as part of general Cardiology study is frequently connected to Task force, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
His study in Acute coronary syndrome is interdisciplinary in nature, drawing from both Clopidogrel, Adverse effect and Lipoprotein.
His Myocardial infarction study integrates concerns from other disciplines, such as Logistic regression, Emergency medicine and Cardiac catheterization.
The various areas that Matthew T. Roe examines in his Percutaneous coronary intervention study include Disadvantaged and Conventional PCI.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
